Lipsitch M - Search Results

1

Interpreting vaccine efficacy trial results for infection and transmission.

Lipsitch M, Kahn R. Lipsitch M, et al. medRxiv [Preprint]. 2021 May 27:2021.02.25.21252415. doi: 10.1101/2021.02.25.21252415. medRxiv. 2021. PMID: 33655276 Free PMC article. Updated. Preprint.

2

Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials.

Kahn R, Hitchings M, Bellan S, Lipsitch M. Kahn R, et al. Among authors: lipsitch m. Clin Trials. 2018 Apr;15(2):207-211. doi: 10.1177/1740774517752671. Epub 2018 Jan 27. Clin Trials. 2018. PMID: 29374974 Free PMC article.

3

Choices in vaccine trial design in epidemics of emerging infections.

Kahn R, Rid A, Smith PG, Eyal N, Lipsitch M. Kahn R, et al. Among authors: lipsitch m. PLoS Med. 2018 Aug 7;15(8):e1002632. doi: 10.1371/journal.pmed.1002632. eCollection 2018 Aug. PLoS Med. 2018. PMID: 30086139 Free PMC article.

4

Analyzing Vaccine Trials in Epidemics With Mild and Asymptomatic Infection.

Kahn R, Hitchings M, Wang R, Bellan SE, Lipsitch M. Kahn R, et al. Among authors: lipsitch m. Am J Epidemiol. 2019 Feb 1;188(2):467-474. doi: 10.1093/aje/kwy239. Am J Epidemiol. 2019. PMID: 30329134 Free PMC article.

5

Antibody testing will enhance the power and accuracy of COVID-19-prevention trials.

Lipsitch M, Kahn R, Mina MJ. Lipsitch M, et al. Nat Med. 2020 Jun;26(6):818-819. doi: 10.1038/s41591-020-0887-3. Nat Med. 2020. PMID: 32341581 No abstract available.

6

Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study.

Peak CM, Kahn R, Grad YH, Childs LM, Li R, Lipsitch M, Buckee CO. Peak CM, et al. Among authors: lipsitch m. Lancet Infect Dis. 2020 Sep;20(9):1025-1033. doi: 10.1016/S1473-3099(20)30361-3. Epub 2020 May 20. Lancet Infect Dis. 2020. PMID: 32445710 Free PMC article.

7

Comparative Impact of Individual Quarantine vs. Active Monitoring of Contacts for the Mitigation of COVID-19: a modelling study.

Peak CM, Kahn R, Grad YH, Childs LM, Li R, Lipsitch M, Buckee CO. Peak CM, et al. Among authors: lipsitch m. medRxiv [Preprint]. 2020 Apr 26:2020.03.05.20031088. doi: 10.1101/2020.03.05.20031088. medRxiv. 2020. PMID: 32511440 Free PMC article. Updated. Preprint.

8

Potential biases arising from epidemic dynamics in observational seroprotection studies.

Kahn R, Kennedy-Shaffer L, Grad YH, Robins JM, Lipsitch M. Kahn R, et al. Among authors: lipsitch m. medRxiv [Preprint]. 2020 May 6:2020.05.02.20088765. doi: 10.1101/2020.05.02.20088765. medRxiv. 2020. PMID: 32511485 Free PMC article. Updated. Preprint.

9

Practical considerations for measuring the effective reproductive number, R _t.

Gostic KM, McGough L, Baskerville EB, Abbott S, Joshi K, Tedijanto C, Kahn R, Niehus R, Hay J, De Salazar PM, Hellewell J, Meakin S, Munday J, Bosse NI, Sherrat K, Thompson RN, White LF, Huisman JS, Scire J, Bonhoeffer S, Stadler T, Wallinga J, Funk S, Lipsitch M, Cobey S. Gostic KM, et al. Among authors: lipsitch m. medRxiv [Preprint]. 2020 Aug 28:2020.06.18.20134858. doi: 10.1101/2020.06.18.20134858. medRxiv. 2020. PMID: 32607522 Free PMC article. Updated. Preprint.

10

Potential Biases Arising From Epidemic Dynamics in Observational Seroprotection Studies.

Kahn R, Kennedy-Shaffer L, Grad YH, Robins JM, Lipsitch M. Kahn R, et al. Among authors: lipsitch m. Am J Epidemiol. 2021 Feb 1;190(2):328-335. doi: 10.1093/aje/kwaa188. Am J Epidemiol. 2021. PMID: 32870977 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

466 results

Search Page